Are inflammation-based markers useful in patients with hepatocellular carcinoma and clinically significant portal hypertension after liver resection?
Keyword(s):
Keyword(s):
Keyword(s):
2011 ◽
Vol 17
(46)
◽
pp. 5083
◽
2016 ◽
Vol 40
(7)
◽
pp. 1709-1719
◽
Keyword(s):
2014 ◽
Vol 15
(4)
◽
pp. 1649-1654
◽
Keyword(s):